Is there a difference between Parkinson disease patients and a control group in terms of urinary symptoms and quality of life?

Background/aim: The aim of this study is to research whether urinary symptoms and disruption of quality of life observed in Parkinson disease patients are different than those of their healthy peers. Additionally, whether these complaints were affected by characteristics such as age at onset of Parkinson disease, sex, disease duration, and severity was investigated. Materials and methods: This study comprised a total of 79 individuals, 39 Parkinson patients and a control group of 40 individuals. Parkinson diagnosis was provided by a neurology expert according to the UK Parkinson's Disease Society Brain Bank Criteria. All patients were evaluated by a urologist with the International Prostate Symptom Score (IPSS) and an overactive bladder (OAB) questionnaire. Results: Compared with the control group, the Parkinson patient group had statistically significantly higher rates of urological complaints (P < 0.001), irritative symptoms (P < 0.001), voiding symptoms (P < 0.001), OAB score (P < 0.001), IPSS total score (P = 0.007), and treatment requirements (P < 0.001). Conclusion: Urologic complaints were observed more frequently in the Parkinson patient group compared to the control group. Another important result of this study is that in the Parkinson patient group there was no difference found between urologic complaints in terms of sex.
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Erdal BENLİ, Fahriye Feriha ÖZER, Yasemin KAYA, Tuba Şaziye ÖZCAN, Ali AYYILDIZ

Suzana MUSTAFA, Norul Badriah HASSAN, Soo Choon TAN, Mahiran MUSTAFA, Ahmad Kashfi Ab RAHMAN, Lee Lee LOW, Wan Nazirah Wan YUSUF

Cytomegalovirus hepatitis in 49 pediatric patients with normal immunity

Hasan TEZER, Ceyda TUNA KIRSAÇLIOĞLU, Saliha KANIK YÜKSEK, Aslı Nur ÖZKAYA PARLAKAY, Belgin GÜLHAN

New immunohistochemical markers in the differential diagnosis of nonsmall cell lung carcinoma

Ferda BİR, Arzu YAREN, Tamer EDİRNE, Duygu ÇELİKER, Binnaz Fatma EVYAPAN

Mehmet Akif DURAK, Mustafa Namik ÖZTANIR, Neşe Başak TÜRKMEN, Osman ÇİFTÇİ, Asli TAŞLIDERE, Mehmet TECELLİOĞLU, Arif ÖNDER

Surgical management of large-cell neuroendocrine lung carcinoma: an analysis of 25 cases

Koray AYDOĞDU, Göktürk FINDIK, Funda DEMİRAĞ, Sadi KAYA, Selim Şakir Erkmen GÜLHAN, Funda İNCEKARA, Ebru SAYILIR

Management of acute postoperative hypertension for reducing cardiovascular complications in cancer patients: when and how aggressively?

Ning LOU, Daofeng WANG, Zhi WANG, Wenfeng YE, Xiao LIU

Growing OXA-23 type strains among carbapenem-resistant Acinetobacter baumannii and tigecycline as an alternate combination therapy

Belgin ALTUN, Ufuk ÖNDE, Zeliha KOÇAK TUFAN, Sami KINIKLI, Ali Pekcan DEMİRÖZ, Şerife ALTUN

Association of neutrophil/lymphocyte ratio with the degree of interstitial lung disease in systemic sclerosis

Gözde YILDIRIM ÇETİN, Ayşe BALKARLI, Nurhan ATİLLA

Feride YARAR, Uğur CAVLAK, Bilge Başakci ÇALIK